An R package for generic modular response analysis and its application to estrogen and retinoic acid receptor crosstalk.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 03 2021
Historique:
received: 09 10 2020
accepted: 09 03 2021
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 21 10 2021
Statut: epublish

Résumé

Modular response analysis (MRA) is a widely used inference technique developed to uncover directions and strengths of connections in molecular networks under a steady-state condition by means of perturbation experiments. We devised several extensions of this methodology to search genomic data for new associations with a biological network inferred by MRA, to improve the predictive accuracy of MRA-inferred networks, and to estimate confidence intervals of MRA parameters from datasets with low numbers of replicates. The classical MRA computations and their extensions were implemented in a freely available R package called aiMeRA ( https://github.com/bioinfo-ircm/aiMeRA/ ). We illustrated the application of our package by assessing the crosstalk between estrogen and retinoic acid receptors, two nuclear receptors implicated in several hormone-driven cancers, such as breast cancer. Based on new data generated for this study, our analysis revealed potential cross-inhibition mediated by the shared corepressors NRIP1 and LCoR. We designed aiMeRA for non-specialists and to allow biologists to perform their own analyses.

Identifiants

pubmed: 33790340
doi: 10.1038/s41598-021-86544-0
pii: 10.1038/s41598-021-86544-0
pmc: PMC8012374
doi:

Substances chimiques

Neoplasm Proteins 0
Receptors, Retinoic Acid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7272

Références

Mol Endocrinol. 2013 Sep;27(9):1429-41
pubmed: 23885094
J Theor Biol. 2005 Feb 7;232(3):427-41
pubmed: 15572066
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Physiol Rev. 2007 Jul;87(3):905-31
pubmed: 17615392
J Biol Chem. 2003 Nov 7;278(45):43889-92
pubmed: 14506269
J Biol Chem. 2005 Mar 4;280(9):7829-35
pubmed: 15632153
Transl Oncol. 2018 Oct;11(5):1090-1096
pubmed: 30007204
Bioinformatics. 2018 Sep 1;34(17):i997-i1004
pubmed: 30423075
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12841-6
pubmed: 12242336
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Mol Cell. 2003 Jan;11(1):139-50
pubmed: 12535528
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Bioinformatics. 2011 Feb 1;27(3):431-2
pubmed: 21149340
Nat Cell Biol. 2007 Mar;9(3):324-30
pubmed: 17310240
Mol Syst Biol. 2012;8:601
pubmed: 22864383
Cell. 2009 Jun 26;137(7):1259-71
pubmed: 19563758
J Steroid Biochem Mol Biol. 2003 Jul;86(1):1-14
pubmed: 12943740
Luminescence. 2001 Mar-Apr;16(2):153-8
pubmed: 11312541
Mol Syst Biol. 2013 Jun 18;9:676
pubmed: 23774759
Mol Syst Biol. 2013;9:673
pubmed: 23752269
Bioinformatics. 2018 Dec 1;34(23):4079-4086
pubmed: 29931053
Mol Endocrinol. 2005 Jun;19(6):1584-92
pubmed: 15831516
Sci Rep. 2018 Nov 1;8(1):16217
pubmed: 30385767
NPJ Syst Biol Appl. 2019 May 23;5:19
pubmed: 31149348
BMC Syst Biol. 2013 Jul 06;7:57
pubmed: 23829771
EMBO J. 1995 Aug 1;14(15):3741-51
pubmed: 7641693
Genes Dev. 2010 Jan 15;24(2):171-82
pubmed: 20080953
Oncogene. 2017 Aug 17;36(33):4790-4801
pubmed: 28414308

Auteurs

Gabriel Jimenez-Dominguez (G)

Inserm U1194, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
University of Montpellier, Montpellier, France.
ICM, Institut régional du Cancer de Montpellier, 208 avenue des Apothicaires, 34298, Montpellier cedex 5, France.

Patrice Ravel (P)

Inserm U1194, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
University of Montpellier, Montpellier, France.
ICM, Institut régional du Cancer de Montpellier, 208 avenue des Apothicaires, 34298, Montpellier cedex 5, France.

Stéphan Jalaguier (S)

Inserm U1194, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
University of Montpellier, Montpellier, France.
ICM, Institut régional du Cancer de Montpellier, 208 avenue des Apothicaires, 34298, Montpellier cedex 5, France.

Vincent Cavaillès (V)

Inserm U1194, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France. vincent.cavailles@inserm.fr.
University of Montpellier, Montpellier, France. vincent.cavailles@inserm.fr.
ICM, Institut régional du Cancer de Montpellier, 208 avenue des Apothicaires, 34298, Montpellier cedex 5, France. vincent.cavailles@inserm.fr.

Jacques Colinge (J)

Inserm U1194, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France. jacques.colinge@inserm.fr.
University of Montpellier, Montpellier, France. jacques.colinge@inserm.fr.
ICM, Institut régional du Cancer de Montpellier, 208 avenue des Apothicaires, 34298, Montpellier cedex 5, France. jacques.colinge@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH